Hologic Inc (HOLX): Today's Featured Health Services Loser

Hologic ( HOLX) pushed the Health Services industry lower today making it today's featured Health Services loser. The industry as a whole closed the day up 0.8%. By the end of trading, Hologic fell 24 cents (-1.4%) to $16.97 on light volume. Throughout the day, 2.5 million shares of Hologic exchanged hands as compared to its average daily volume of 3.4 million shares. The stock ranged in price between $16.93-$17.30 after having opened the day at $17.27 as compared to the previous trading day's close of $17.21. Other company's within the Health Services industry that declined today were: Urologix ( ULGX), down 13.7%, Tengion ( TNGN), down 5.9%, Mela ( MELA), down 5.5%, and IntegraMed America ( INMD), down 5.4%.

Hologic Inc. develops, manufactures, and supplies diagnostic, medical imaging systems, and surgical products for the healthcare needs of women. The company operates in four segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. Hologic has a market cap of $4.54 billion and is part of the health care sector. The company has a P/E ratio of 19.7, below the average health services industry P/E ratio of 100.9 and above the S&P 500 P/E ratio of 17.7. Shares are down 1.7% year to date as of the close of trading on Wednesday. Currently there are 14 analysts that rate Hologic a buy, no analysts rate it a sell, and seven rate it a hold.

TheStreet Ratings rates Hologic as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and unimpressive growth in net income.

On the positive front, BSD Medical Corporation ( BSDM), up 18.6%, Dehaier Medical Systems ( DHRM), up 13.1%, NeuroMetrix ( NUROD), up 12.1%, and D Medical Industries ( DMED), up 11.8%, were all gainers within the health services industry with Covidien ( COV) being today's featured health services industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

If you liked this article you might like

These Stocks Are Ready to Reverse Course

Hologic Looks Good on the Charts

Five S&P 500 Boards Have No Women as Gender Balance Growth Stalls

Merck Up on Approval, Teva Sinks on Earnings and Asset Sales: Biotech Movers

Cramer: These Sectors Look Bullish (Part III)